By Drug Class / Mechanism

Menthol-Based Counterirritant Market Analysis

Cross-industry research covering Menthol-Based Counterirritant across 1 market reportspanning Pharmaceuticals.

1 Reports

1 Industries

Reports Covering Menthol-Based Counterirritant

Medical Cold Gel Market to Reach USD 1.8 Billion by 2033 at 5.2% CAGR

Pharmaceuticals·Market: USD 1.21 Billion (2025)·CAGR: 5.2%

Menthol activates TRPM8 cold receptors and is the dominant active ingredient in branded OTC cold gels including Biofreeze, Mentholatum, and Salonpas product lines. USP monograph compliance governs menthol purity and concentration, providing a formulation floor that limits differentiation.

45%

Market Share

5.0%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments